Paushak Ltd
NSE: PAUSHAKLTD BSE: 532742
₹449.35
(1.29%)
Mon, 25 May 2026, 05:18 pm
Market Cap11.23B
PE Ratio28.18
Dividend0.55
Process Industries
Chemicals: Major Diversified
24.5KPaushak Analysis
dividend
- Paushak is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
- No need to calculate the sustainability of Paushak's dividends as it is not paying a notable one for India.
- Paushak is not paying a notable dividend for India, therefore no need to check if the payments are stable.
- Paushak's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Paushak's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
- Paushak is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Paushak is profitable, therefore cash runway is not a concern.
- Paushak is profitable, therefore cash runway is not a concern.
- Paushak has no debt, it does not need to be covered by operating cash flow.
- Paushak has no debt, it does not need to be covered by short term assets.
- Paushak's cash and other short term assets cover its long term commitments.
- Paushak has no debt compared to 5 years ago when it was 0.4%.
- Paushak has no debt, therefore coverage of interest payments is not a concern.
- Paushak has no debt.
- High level of physical assets or inventory.
management
- The tenure for the Paushak board of directors is about average.
- Abhijit's compensation has been consistent with company performance over the past year, both up more than 20%.
- The average tenure for the Paushak management team is over 5 years, this suggests they are a seasoned and experienced team.
- Abhijit's remuneration is higher than average for companies of similar size in India.
misc
- Paushak is not covered by any analysts.
past
- Paushak has delivered over 20% year on year earnings growth in the past 5 years.
- Paushak used its assets more efficiently than the IN Chemicals industry average last year based on Return on Assets.
- Paushak has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
- Paushak's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Paushak has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Paushak's 1-year earnings growth is negative, it can't be compared to the IN Chemicals industry average.
value
- Paushak's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Paushak's share price is below the future cash flow value, and at a substantial discount (> 40%).
- 532742 outperformed the Market in India which returned -14.5% over the past year.
- BSE:532742 is up 6.4% along with the Chemicals industry (6.9%) over the past month.
- Paushak is overvalued based on assets compared to the IN Chemicals industry average.
- Paushak is overvalued based on earnings compared to the IN Chemicals industry average.
- Paushak is overvalued based on earnings compared to the India market.
- 532742 underperformed the Chemicals industry which returned 2.2% over the past year.
- BSE:532742 is up 6.4% underperforming the market in India which returned 8% over the past month.